A tobacco company's new, dissolvable nicotine pellet--which is being sold as a tobacco product, but which in some cases resembles popular candies--could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health (HSPH), the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The researchers also say the candy-like products could appeal to young people and le...

That first "mini-stroke" may be more of a benign event for women than men, according to researchers at the University of Alabama at Birmingham (UAB) and Yale University. The findings underscore the need to continue researching gender differences in disease prevention and follow-up care.

Data show 30 days after a transient ischemic attack (TIA), women are 30 percent less likely to have a stroke, 14 percent less likely to have heart-related problems and 26 percent less likely to die than m...

LSTM has launched a collaborative project to develop and evaluate new tools to control the spread of malaria in Africa. AvecNet is a five year, 12 million euro project involving sixteen partners in Africa and Europe, funded by the European Union's Seventh Framework programme. Because malaria is transmitted by mosquitoes, their effective control is essential to combating the disease. Wide scale use of insecticides on bednets and in interior spraying programmes has dramatically reduced transmissi...

Up to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an antiplatelet response from aspirin, the effect thought to produce the protective effect, researchers at the University at Buffalo have shown.

"Millions of people use low-dose aspirin either for prevention of a second stroke, second heart attack or second episode of peripheral artery disease," said Francis M. Gengo, Pharm.D., lead researcher on the study.

Geng...

StemCellPatents, an organization that covers recent news in stem cell therapeutics and has assembled the only comprehensive index of all issued U.S. stem cell patents, congratulates International Stem Cell Corporation (OTCBB:ISCO) on its recent developments, including being the first company to grow human corneal tissue from stem cells.

ISCO, the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, recently created layered human tissue...

Tag Cloud